← back to search

José M. Martinez-Navío

University of Miami · US
Area of research
Virology · Epidemiology
Research interest
Research interests include HIV Research and Treatment, Virus-based gene therapy research, Cytomegalovirus and herpesvirus research, and Immune Cell Function and Interaction.
h-index
18
citations
1,498
works
41
NIH funding
primary concept
email

Recent publications

Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life
Nature 2025cited by 10position: middledoi
Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies
Nature Communications 2025cited by 2position: middledoi
High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
Molecular Therapy — Methods & Clinical Development 2022cited by 28position: middledoi
Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
Frontiers in Immunology 2020cited by 47position: firstdoi
Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
Molecular Therapy — Methods & Clinical Development 2020cited by 12position: middledoi
Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
Immunity 2019cited by 128position: firstdoi
Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
Molecular Therapy 2019cited by 58position: middledoi
Liver-Directed but Not Muscle-Directed AAV-Antibody Gene Transfer Limits Humoral Immune Responses in Rhesus Monkeys
Molecular Therapy — Methods & Clinical Development 2019cited by 29position: middledoi
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
Journal of Virology 2017cited by 23position: middledoi
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus
PLoS neglected tropical diseases 2017cited by 22position: middledoi
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys
Molecular Therapy 2017cited by 14position: middledoi
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
PLoS ONE 2016cited by 19position: middledoi
AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
Nature 2015cited by 301position: middledoi
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
PLoS Pathogens 2015cited by 99position: middledoi
Host Anti-antibody Responses Following Adeno-associated Virus–mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys
Molecular Therapy 2015cited by 75position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sebastian Fuchs · University of Miami14 papers (2015–2025)Ronald C. Desrosiers · University of Miami14 papers (2015–2025)Guangping Gao · Institute for Biomedical Research and Innovation12 papers (2015–2025)Eva G. Rakasz · Wisconsin Department of Health Services5 papers (2015–2020)Jeffrey D. Lifson · Center for Cancer Research5 papers (2015–2025)Maurício A. Martins · Scripps Research Institute4 papers (2017–2025)Diogo M. Magnani · UMass Memorial Health Care4 papers (2017–2025)Lucas Gonzalez-Nieto · University of Miami3 papers (2017–2017)David I. Watkins · George Washington University3 papers (2017–2017)Varian K. Bailey · University of Miami3 papers (2017–2017)Stephen S. Whitehead · National Institutes of Health3 papers (2017–2017)Michael J. Ricciardi · Noblis3 papers (2017–2017)Esper G. Kallás · Instituto Butantan3 papers (2017–2017)Cássia Gisele Terrassani Silveira · Universidade de São Paulo3 papers (2017–2017)Aline Domingues · University of Miami3 papers (2017–2017)Dennis R. Burton · Scripps Research Institute3 papers (2017–2017)Martin J. Gutman · University of Miami3 papers (2017–2017)Núria Pedreño-López · IrsiCaixa3 papers (2017–2017)Helen S. Maxwell · University of Miami3 papers (2017–2017)Matthew R. Gardner · Emory University3 papers (2019–2025)